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Fever of Unknown Origin (FUO)
I. A prospective multicenter study of 167 patients 
with FUO, using fixed epidemiologic entry criteria
E l i s a b e t h  M. H. A. d e  K le i jn ,  M.D., J a n  P. V a n d e n b r o u c k e ,  M.D.,
Jo s  W. M. VAN DER MEER, M.D., AND THE NETHERLANDS FUO STUDY GROUP*
Introduction
Fever of unknown origin (FUO) is a challenging 
medical problem. Petersdorf and Beeson (30) de­
fined FUO as an illness characterized by rectal tem­
perature exceeding 38.3 °C on at least 3 occasions, 
evolving during at least 3 weeks, with no diagnosis 
reached after 1 week of inpatient investigation. 
Many retrospective (2, 4, 5, 12, 15, 18, 20, 28, 32, 34, 
35) and a few prospective (1, 16, 19, 23, 25) studies 
of patients with FUO have been performed using 
this definition. Other series have used different cri­
teria (3, 9-11, 14 ,17, 21, 24, 27, 31, 33, 36), and their 
results are more difficult to interpret. A more re­
cently revised definition (8, 23, 29) that excludes 
immunocompromised patients has not been em­
ployed in major series yet.
The spectrum of diseases causing FUO not only 
seems to be determined by geographical factors, 
but also appears to change with time. In recent se­
ries, the proportion of patients in wiiom no diagno­
sis was made has increased compared with older 
series (23, 28). In addition, comparison is trouble­
some because, on the one hand, most studies do 
not use uniform epidemiologic entry criteria, thus 
possibly introducing unintended bias, and, on the 
other hand, differences in diagnostic workup can 
influence the outcome. Consequently, uniform en­
try criteria and continuous auditing for complete­
ness are necessary, and a standardized diagnostic 
workup is preferable.
To update information on FUO and incorporate 
these new ideas, we conducted a prospective, 
2-year study on patients with FUO in all 8 Dutch 
university hospitals, in which we excluded 
immunocompromised patients and used a stan­
dardized protocol to minimize diversity in diagnos­
tic management. This protocol was based on 
retrospective analysis of diagnostic management 
(5) and an in-depth inquiry into diagnostic manage­
ment among internists in the 8 Dutch university 
hospitals (6).
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Methods
The present study was undertaken from January 1992 to Jan­
uary 1994. Because we wanted to enroll all admitted patients ful­
filling criteria for FUO, without any unintended selection bias, 2 
very broad initial selection criteria were used. First, all records 
of nonimmunocompromised patients with fever on the internal 
medicine wards in all 8 university hospitals in the Netherlands 
were reviewed for the Petersdorf criteria for FUO once a week 
(illness characterized by rectal temperature exceeding 38.3 °C, 
evolving during at least 3 weeks, with no diagnosis after 1 week 
of inpatient investigation). Total bed capacity of each of the 8 
university hospitals ranged from 715 to 1,260 beds. Immuno­
compromised patients wrere considered patients with neutrope­
nia for at least 1 week within 3 months before the onset of fever 
(white blood cell count <  1.0 x 10!)/L and/or granulocyte <  0.5 
X 109/L); human immunodeficiency virus (HlV)-positive pa­
tients; patients with known hypogammaglobulinemia (IgG < 
50%); and patients using the equivalent of more than 10 mg pred­
nisone for at least 2 weeks. Second, as an additional check, all 
blood culture orders were reviewed weekly at the microbiologic 
laboratory, and the records of the patients in whom blood cul­
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t.ures were ordered were reviewed. The latter procedure was 
added because in a retrospective study (5) we found that in all 
patients with FUO, blood cultures were performed. After thus 
having identified all patients with fever, we applied the Peters- 
dorf and Beeson criteria (30), as described above. By combining 
these 2 methods, we minimized the chance of missing patients 
who fulfilled FUO criteria.
The study was approved by all local ethic committees. After in­
formed consent, patients were included in our FUO protocol, 
which consisted of a standardized precoded history and standard­
ized thorough physical examination. As a minimum, several addi­
tional investigations had to be performed in the first week of 
admission (Table 1). Much weight was given to the presence or ab­
sence of potentially diagnostic clues (PDCs), defined as all local­
izing signs, symptoms, and abnormalities potentially pointing 
toward a possible diagnosis, and the use of these PDCs in the di­
agnostic process. False PDCs are defined as PDCs eventually not 
leading to the definite diagnosis. History, physical examination, 
laboratory and technical investigations, the presence of PDCs, and 
their use in the diagnostic process were prospectively registered 
in a structured data collection form. If PDCs were present, appro­
priate investigations were performed. If PDCs were absent or false 
only, patients underwent a standardized diagnostic protocol (see 
Table 1).
Within 1 week of inclusion in the study, every patient was 
seen by the first author in order to streamline the management 
of the patients. Patients did not have to remain admitted; after 
inclusion all investigations of the protocol could be performed 
on an outpatient basis. The patient’s clinical condition was the 
major reason for a longer stay in the hospital, at the discretion 
of the attending physician. The final diagnosis was established 
by the attending physician and the first author. Definite diag­
noses were established by positive serology, cultures, or histol­
ogy. In some patients probable diagnoses were established by 
excluding other disease, by the response to specific therapy, or 
by studying the course of the disease. A long follow-up was 
deemed indispensable for all patients in whom a final definite di­
agnosis could not be made. A final follow-up was therefore per­
formed more than 2 years later in March 1996, by analysis of the 
records of the patients, telephone calls to the treating physi­
cians, and, in some cases, telephone calls to the patients them­
selves.
Recurrent fever was defined in this study as at least 2 episodes 
of fever, with intervals of at least 48 hours without fever. Data 
were statistically analyzed and groups of patients compared with 
use of the Fisher exact test. A p value of <0.05 (2-sided) was con­
sidered significant.
TABLE 1. Diagnostic protocol
Obligatory investigations performed in all patients
Sedimentation rate; hemoglobin; mean cellular volume; 
platelet count; leukocyte count and differential count; serum 
urea nitrogen; creatinine; sodium; potassium; protein; protein 
fractions; alkaline phosphatase; aminotransferase; lactate de­
hydrogenase; creatine phosphokinase; antinuclear antibodies; 
rheumatoid factors; urinary analysis; feces for occult blood; 
blood cultures aerobic and anaerobic (n = 3); tuberculin test; 
urine, feces, and sputum culture when indicated; chest X-ray; 
ultrasonography of upper abdomen 
Phase 1 diagnostic protocol in patients without PDCs (n = 
5) or with misleading PDCs only (n = 38)
Pulse/rectal temperature measurement by observer; fun- 
doscopy by an ophthalmologist; calcium, phosphate, urate, 
amylase, and TSH/T4; immunoelectrophoresis of serum and 
urine; CRP; ACE; ANCA; anti-dsDNA; ASO; cryoglobulin; C3, 
C4, CH50; serology for Cytomegalovirus, Epstein-Barr virus, 
Mycoplasma, Brucella, Toxoplasma, Bor re Ha, Coxiella, Tre­
ponema, Yersinia; blood cultures incubating >  1 week; blood 
cultures, gastric fluid, urine cultures for tuberculosis; stools 
for worms, eggs, cysts; bone marrow puncture and culture for 
Mycobacteria, Bmcella, Yersinia; In-lll-IgG scintigraphy; X- 
Ray of sinus and teeth; ultrasonography of pelvis 
Phase 2 diagnostic protocol in patients without PDCs 
(Performed when Phase 1 did not reveal PDCs or diagnosis) 
Hepatitis B serology; anergy tests; repeated chest X-ray; IgD in 
serum; liver biopsy and culture for Mycobacteria and other 
bacteria and fungi; crista biopsy and culture for Mycobacteria, 
Brucella, and common bacteria; echocardiography; CT of ab­
domen and chest; X-Ray colon; temporal artery biopsy in pa­
tients over 55 years
Abbreviations: TSII = thyroid-stimulating hormone; T4 = thy­
roxine; CRP = C-reactive peptide; ACE = angiotensin-converting 
enzyme; ANCA = antineutrophil cytoplasmic autoantibodies; ds- 
DNA = double-stranded deoxyribonucleic acid; ASO = antistrep­
tolysin O test; C = complement; CH50 = total hemolytic comple­
ment; In-lll-IgG = indium-ill-labeled polyclonal human 
immunoglobulin G; CT = computed tomography; PDCs = poten­
tially diagnostic clues.
Results
Clinical features
During the 2-year period of study, 167 patients 
(80 male, 87 female) met the criteria for FUO. The 
median age was 53 years (range, 16-87 yr); 46 pa­
tients (28%) were older than 65 years. Of these pa­
tients, 139 patients were found by reviewing 
weekly the records of all patients with fever; in all 
of these patients blood cultures were done. By 
means of blood culture surveys an additional 28 pa­
tients were retrieved that fulfilled FUO criteria and 
wTere not recognized as such when checking the 
records.
Sixty-five (39%) patients were referred by gen­
eral practitioners and 64 (38%) had already under­
gone extensive investigations before referral to a 
university hospital, whereas 7 patients (4%) were 
referred by other departments within the university 
hospitals, and 31 patients (19%) were already 
known with other nonfebrile conditions at the uni­
versity department. The proportion of patients in 
whom no diagnosis could be made was slightly 
lower, albeit not significantly, for patients referred 
by general practitioners (26%) than for secondarily 
referred patients (33%). For the 117 patients with a 
diagnosis, a diagnosis was established after a me­
dian of 60.5 days from the onset of fever (range,
21-1,584 d) in those referred by general practition­
ers, whereas in patients referred by non-university 
hospitals it took a median of 166 days (range,
22-3,347 d) (p = 0.005).
Median overall follow-up after admission was 854
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days (range, 10-3,387 d). In 30 patients (18%) follow- 
up was less than 0.5 years. Fifteen of these 30 pa­
tients died within this period, only 1 of them without 
a diagnosis. In the other 15 patients, diagnosis was 
proved in 14 patients. One patient with probable ve­
nous thrombosis as the cause of her fever could not 
be traced during follow-up. The median follow-up of 
50 patients without a diagnosis and 48 patients with 
a probable diagnosis was 1,080 days (range, 15-3,387 
d). In only 3 of these 98 patients was follow-up less 
than 1 year.
Median duration of hospitalization was 27 days 
(range, 7-295 d). The median duration of fever in the 
group of 117 patients in whom a diagnosis was made 
was 78.5 days (range, 21-8,804 d). Of the 50 (30%) pa­
tients in whom no diagnosis was made, 37 patients 
recovered spontaneously after a median of 190 days 
(range, 30-13,844 d). Thirteen patients remained 
febrile; these patients had a median duration of fever 
of 1,021 days (range, 481-5,281 d). Except for 1 pa­
tient, patients with persistent fever all had some form 
of recurrent fever.
Recurrent fever was present in 56 patients. In 28 of 
those patients (50%), no diagnosis could be estab­
lished, in contrast to 22 of 111 patients (20%) with 
continuous fever (p < 0.0001).
In 67 patients the fever lasted longer than 6 
months. In 37 (55%) patients no diagnosis could be 
made, in contrast to 18 of 100 (18%) patients with 
fever lasting less than 6 months (p < 0.0001).
Diagnosis and outcome
%
In the 117 patients in whom a diagnosis was made, 
the diagnostic phase in the university hospital (after 
referral) took a median of 33 days (range, 1-1,297 d). 
In 42 patients the diagnosis was made after discharge 
during follow-up because of new emerging facts. Of 
the 167 patients in this series, 20 patients died during 
follow-up: in 18 of them a diagnosis was made, in 4 
not until after autopsy. All but 1 patient succumbed 
to the disease responsible for the FUO. Infections 
were found in 43 (26%) patients, neoplasms in 21 
(13%), and noninfectious inflammatory diseases in 40 
(24%) patients (Table 2).
Infections: In 4 patients, abscesses were the 
cause of fever. In 2 patients these were liver ab­
scesses, caused in the first patient by Escherichia 
coli, Proteus mirabilis, and Bacteroides fragilis , 
while in the second patient the abscess was culture 
negative at autopsy after empirical antibiotic ther­
apy. The delay of diagnosis in these patients was 
due to inconclusive ultrasound examinations. In 
the first patient, the second ultrasonography re­
vealed multiple abscesses in the liver; in the other 
patient a biopsy of the liver yielded the diagnosis.
In the last 2 patients pelvic abscesses were the 
cause of fever, caused in 1 patient by Peptococcus 
species, and in the other patient by Escherichia 
coli and Streptococcus milleri. In these patients the 
delay was due to failure to order pelvic ultrasonog­
raphy because of the absence of lower abdominal 
pain.
There were 2 patients with pleural empyema. In
1, the chest radiography was incorrectly interpreted, 
resulting in a delay in the diagnosis. Scintigraphy and 
thoracic computed tomography (CT) led to the diag­
nosis, and culture of pleural fluid grew Peptococcus 
species. In the second patient, pleural fluid cultures 
were sterile, but pleural biopsies yielded Actino­
myces species.
In 5 patients urinary trac t infection turned out 
to be the cause of fever; 2 of them received antibi­
otics for other presumed infections at the time of the 
first urine culture. In both patients, urine cultures 
yielded Klebsiella pneumoniae eventually. In the 
third patient, recurrent prostatitis was found by 
transrectal sonography, and culture of prostatic 
secretion yielded Klebsiella pneumoniae. In the 
fourth patient, chronic xanthogranulomatous 
pyelonephritis with obstruction of the ureter was 
demonstrated by abdominal CT; cultures of mine 
and blood remained negative. In the fifth patient, bal­
anitis accompanied the urinary infection, cultures 
yielded Escherichia coli, and, after circumcision, 
fever subsided.
Endocarditis was found in 4 patients. Culture- 
negative endocarditis occurred in 2 patients, and 
the diagnosis was not made until autopsy by histol­
ogy. In 1 of these 2 patients echocardiography had 
been negative, in the other echocardiography was 
not performed, because false PDCs were present. 
In the third patient, cultures became positive for 
Streptococcus bovis when empiric antibiotic ther­
apy was stopped. In the fourth patient, blood cul­
tures were not drawn in the referring hospital and 
empirical antibiotics were given. Because of dete­
rioration the patient was referred to our hospital, 
and 2 days later blood cultures yielded Staphylo­
coccus aureus.
In 6 patients a clinical picture of pneum onia was 
present. In all patients chest X-rays showed seg­
mental infiltrates consistent with bronchopneumo­
nia. In 3 patients bronchoscopy with culture of 
bronchial fluid and serology for respiratory 
viruses, Chlamydia, Legionella, Mycoplasma 
pneumoniae, and Coxiella bimietii were negative 
and thus no causative microorganism could be 
found. The first patient also had mediastinal lym- 
phadenopathy and some pleural effusion and had 
already received extensive antibiotic therapy 
(cephalosporin, amoxicillin, flucloxacillin, and to­
bramycin) elsewhere without disappearance of
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TABLE 2. Final diagnoses in 167 patients with fever of unknown origin
Diagnostic Category No. of Patients (%)
Infections 43 (25.7)
Bacterial*
Abscess/lung empyema1' 6
Urinary tract infections 5
Endocarditis 4
Atypical or recurrent pneumonia 6
Tuberculosis 3
Other bacterial infections 12
Viral
Cytomegalovirus infection 5
Other viral infections* 2
Fungal
Disseminated cryptococcal infection 1
Neoplasms* 21 (12.6)
Hematologic 14
Solid 7
Noninfectious inflammatory diseases 40 (24.0)
Collagen diseases 19 (11.4)
Adult-onset Still disease* 6
Mixed cryoglobulinemia 5
Other* 8
Vasculitis syndromes 14 (8.4)
Temporal arteritis 4
Other* 10
Granulomatous diseases 7 (4.2)
Inflammatory bowel diseases 2
Sarcoidosis 2
Other* 3
Drug fever 3 (1.8)
Factitious fever 2 (1.2)
Miscellaneous* 8 (4.8)
No diagnosis 50 (29.9)
Spontaneous recovery 37
Persistent fever 13
*See Results Section for details.
fOne patient with urinary tract infection also.
fever. After referral, he recovered spontaneously 
after 8 weeks of fever. The second patient had 
received doxycycline, amoxicillin, gentamicin, 
cephazolin, and erythromycin without improve­
ment of his condition. Isoniazid, rifampin, and 
pyrazinamide were given for 6 weeks without effect 
and stopped when cultures for tuberculosis 
remained negative. He recovered spontaneously 
over a 6-month period thereafter. The third patient 
was treated with penicillin, erythromycin, and 
rifampin for 4 weeks; after this period the patient’s 
temperature was below 38 °C, antibiotic therapy 
was stopped, and the patient recovered further 
during the next 2 weeks. In the fourth patient 
with pneumonia, Haemophilus influenzae and 
Stenotrophomonas maltophilia were cultured first; 
after antibiotic therapy with cefuroxime, fever 
persisted. A second culture after stopping therapy 
revealed Moraxella cattarrhalis; antibiotic therapy 
with amoxicillin-clavulanate was successful. In 
the fifth patient, Pseudomonas aeroginosa was 
cultured. She was treated with ceftazidime 
intravenously, but fever persisted. Because of a
history of tuberculosis in the past, she was then 
treated with isoniazid, pyrazinamide, and rifampin 
without result. Repeated bronchoscopic exam­
ination and culture of bronchial fluid yielded 
Pseudomonas aeroginosa again. After several 
weeks of therapy with ciprofloxacin, she recovered. 
In the sixth patient with pneumonia, Haemophilus 
influenzae and Stenotrophomonas maltophilia 
were cultured. Erythromycin had already been given 
empirically without any effect, and ciprofloxacin 
was added. By then Klebsiella pneumoniae had 
been cultured from the urine also. We concluded 
that this patient had 2 different infections causing 
the FUO. It took more than 20 days for her to recover 
and her temperature to normalize.
Tuberculosis was proved in 3 patients by cul­
ture. In the first patient, pericardial puncture re­
vealed the diagnosis. In the second patient, a 
positive purified protein derivative (PPD) test and 
erythema nodosum suggested tuberculosis, but no 
localization seemed present after inclusion. A so­
matostatin scintigraphy was performed which 
showed activity high in the axilla. An ultrasono-
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graphic biopsy of enlarged axillary lymph nodes 
showed aeid-fast bacilli. Cultures grew Myco­
bacterium tuberculosis. The third patient had a 
recent history of breast cancer and bone metastasis, 
and lymphangitis carcinomatosis was suspected. 
Corticosteroids were administered empirically. 
Because of deterioration and in accordance with 
the diagnostic protocol, sputum cultures for tub­
erculosis were performed, which showed acid-fast 
bacilli. Cultures grew Mycobacterium tuberculosis 
eventually.
Cytomegalovirus infection was proved in 5 pa­
tients by serology (a fourfold elevation of IgG titer); 
in all but 1 patient lymphocytosis and atypical lym­
phocytes in the blood smear were found initially but 
false PDCs delayed the diagnostic process.
Other bacterial infections included persistent 
Yersinia enterocolitica infection (n = 2), diverticuli­
tis (n = 2), recurrent sinusitis, cholangitis, adnexitis, 
bacterial meningitis in ventriculo-peritoneal drain 
with Escherichia coli, typhoid fever, occult dental 
infection, secondary syphilis, and infected central 
venous device with Staph, epidermidis and Staph, 
aureus.
Neoplasms: In 14 patients hematologic malig­
nancies were found. Hodgkin disease was the 
cause of fever in 5 patients. In 2 patients, the diag­
nostic process was delayed because their fevers 
were erroneously attributed to previously diag­
nosed diseases (systemic lupus erythematosus and 
sarcoidosis). In 2 others there was no lym­
phadenopathy, and diagnosis was made by bone 
marrow biopsy. In the fifth patient there was only 
mediastinal localization of Hodgkin disease. In 4 pa­
tients non-Hodgkin lymphomas were the cause of 
fever. In the first of these patients, very small ab­
dominal lymph nodes were found by abdominal CT,
3 years after successful allogenic bone marrow 
transplantation. Positive yersinia serology (Western 
blot) delayed diagnostic laparotomy in a second pa­
tient with abdominal lymphadenopathy. The third 
patient had a 3-year history of recurrent fever. Only 
misleading PDCs were present during first admis­
sion in the university hospital, and, because fever 
subsided, the standardized diagnostic protocol was 
not used. During the next episode of fever, anemia 
developed and bone marrow biopsy revealed non- 
Hodgkin lymphoma. The fourth patient had an 18- 
year history of progressive polyneuropathy, 
telangiectasis, muscle weakness, hepatomegaly, 
and lymphadenopathy. Despite a large series of ex­
tensive investigations, a diagnosis was never estab­
lished. She had never been febrile before inclusion 
in our study, when a malignant T-cell tumor was 
identified. Other hematologic malignancies were 
angio-immunoblastic lymphoma (n = 2), acute
leukemia, acute myelofibrosis, and gamma-heavy- 
chain disease (Franklin disease).
In 7 patients a variety of solid tumors was re­
sponsible for the fever. Primary tumors were found 
in 2 patients, 1 with breast cancer and 1 with stom­
ach cancer. Metastasis of breast cancer (n = 2), lar­
ynx cancer, and adenocarcinoma of unknown origin 
were found in 4 other patients. In the seventh patient, 
necrosis of a dermoid tumor in Gardner syndrome 
was responsible for the FUO.
Noninfectious inflammatoi'y diseases 
—Collagen diseases: The diagnosis of adult-onset 
Still disease was made in 6 patients. All patients met 
the Medsger and Christy criteria for adult-onset Still 
disease (26), but the diagnosis was made only after 
prolonged observation and exclusion of other dis­
eases. Other collagen diseases found in this series were 
mixed cryoglobulinemia (n = 5), systemic lupus ery­
thematosus (n = 2), reactive arthritis (n = 2), 
polymyalgia rheumatica (n = 1), relapse of polymyosi­
tis (n = 1), dermatomyositis (n = 1), and relapse of 
rheumatoid arthritis (n = 1).
— Vasculitis syndromes: Temporal arteritis was 
found in 4 patients. Other vasculitis syndromes 
found in our series were hypersensitivity vasculitis 
(n = 3), polyangiitis overlap syndrome (n = 2), and 
Wegener disease (n = 2); Schnitzler disease (urticar­
ial vasculitis with monoclonal IgM), vasculitis ac­
companying rheumatoid arthritis, and polyarteritis 
nodosa were found in 1 patient each.
—Granulomatous diseases: Two patients had in­
flammatory bowel diseases, and 2 patients had sar­
coidosis. In 2 patients granulomatous hepatitis was 
found, and in 1 patient granulomatous myositis was 
found, without underlying disease as cause of the 
fever.
Miscellaneous diseases: The miscellaneous group 
encompassed aseptic meningitis (Mollaret meningitis) 
without underlying disorders (n = 2); pseudogout (n =
2); and gout, venous thrombosis, hyperthyroidism, and 
allergic pneumonitis after radiation therapy, found in 1 
patient each.
Diagnostic process
PDCs were present in 162 (97%) patients. The 10 
most common PDCs were relevant diseases in past 
(131 patients), weight loss (93 patients), relevant 
operation in past (68 patients), headache (62 pa­
tients), myalgia (58 patients), diarrhea (50 patients), 
vertigo (48 patients), arthralgia (48 patients), heart 
murmur (41 patients), pulmonary abnormalities (38 
patients). These PDCs led to the diagnosis in 101 pa­
tients (62%). In 48 of these 101 patients, false PDCs 
were also present. In 13 patients a diagnosis was
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made despite the presence of false PDCs only. No 
clues were present in 5 patients, in 2 of whom no di­
agnosis was made. There was a small but not signif­
icant difference in reaching the diagnosis between 
patients with clues (73%) or patients without clues 
(60%).
In 16 patients without PDCs or with false PDCs 
only, diagnoses were made with the help of the 
standardized diagnostic protocol. More detailed 
information on PDCs and the use of the diagnostic 
protocol is foimd in our companion article (6a) later 
in this issue.
Discussion
In this prospective multicenter study of 167 pa­
tients, FUO was due to infection in 26% of patients, 
neoplasms in 13%, noninfectious inflammatory dis­
eases (NIID) in 24%, and miscellaneous causes in 
5%, whereas the diagnosis was not established in 
30% of patients despite every effort. This is in agree­
ment with the findings of our retrospective study in 
a single institution (5) and those of other recent se­
ries (23, 28), but in contrast to older reports (Table
3). There are a number of possible explanations for 
this phenomenon. First, 38% of patients were re­
ferred after undergoing extensive investigations 
elsewhere, comparable to the findings of Knock- 
aert et al (28%) (23). In most series of FUO in the lit­
erature, exact data on referral patterns are lacking 
(1, 15, 25,30, 32, 34). One could speculate that more 
difficult-to-diagnose cases are referred, with a 
lower chance of reaching a final diagnosis. In our 
series however, the proportion of patients without 
a diagnosis was only slightly higher in the referred 
group. It is more likely that the introduction of ad­
vanced diagnostic techniques had a major impact. 
In many patients who formerly would have been 
classified as having FUO because of difficulty in 
reaching a diagnosis, a diagnosis now is likely to be 
established. This is especially true for disease enti­
ties such as endocarditis, abdominal abscesses, 
and malignant lymphoma that can be diagnosed 
easily by ultrasonography, a technique used very 
early in the diagnostic process now. This leaves us 
with a group of patients fulfilling classical criteria, 
in whom a diagnosis is much more difficult to make 
with mostly self-limiting or benign fevers. There 
has also been a shift in diseases that cause fever. 
For instance, in nonimmunocompromised patients, 
tuberculosis has become relatively rare. Many in­
fections in our series were due to common mi­
croorganisms. Petersdorf and Beeson (30) 
excluded these disorders because they represented 
common entities, but it is important for attending 
doctors to realize that FUO can be caused by such 
common diseases and microorganisms, which 
might be concealed by false PDCs or the use of an­
tibiotics.
Compared with results of other series from uni­
versity hospitals (20, 28, 30), tumors were not a com­
mon cause of FUO in the present study. This is in 
agreement with our retrospective survey and 1 other 
recent series (15, 23). This could be the result of the 
widespread use of advanced diagnostic techniques 
early in the diagnostic process—for instance, ultra­
sonography, computed tomography, and serologic 
techniques. As expected, some hematologic malig­
nancies remain difficult to diagnose because of the 
lack of localizing symptoms. Metastases can be very 
small, while causing FUO and other paraneoplastic 
symptoms (7). The diagnostic process in patients 
with a history of malignancy should be focused on re­
currence of the tumor.
In contrast to other series, we used a dual 
method to find cases. In this way, all patients that 
presented with FUO were retrieved. It is of interest 
that 3 of the 6 prospectively conducted studies on 
FUO did not mention the way in which cases were 
retrieved (1, 25, 30), and methods in the other 3 
studies (2, 16, 25) still show a degree of selection 
bias because no control system was used to avoid 
missing patients fulfilling FUO criteria. Of course,
TABLE 3. Diagnostic categories in fever o f unknown origin, previous and present studies (%)
Diagnostic
Category
Older Major Series New Series
Ref. 30 
1961
(n = 100)
Ref. 25 
1982
(n = 105)
Ref. 2 
1984
(n = 133)
Ref. 23 
1992
(n = 199)
Present 
Study 
(n = 167)
Infections 36 30 32 22.7 25.7
Neoplasms 19 31 20 7.0 12.6
Noninfectious inflammatory diseases 19 15 16 23.1 24.0
Collagen diseases (13) (5) (3) (8.5) (11.4)
Vasculitis syndromes (2) (4) (11) (10.6) (8.4)
Granulomatous diseases (4) (3) (2) (4.0) (4.2)
Drug fever 1 0 0 3.0 1.8
Factitious fever 3 3 4 3.5 1.2
Miscellaneous 15 8 7 15.1 4.8
No diagnosis 7 13 21 25.6 29.9
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serious selection bias cannot be prevented in ret­
rospective studies.
In accordance with the suggestions made by Du- 
rack and Street (8) and Petersdorf (29) we ex­
cluded immunocompromised patients with FUO, 
because these patients show an entirely different 
spectrum of diseases causing fever. One of the cri­
teria for FUO is admission to hospital for 1 week, 
without a diagnosis being established. This is a 
time-related criterion, which may cause important 
differences as it is dependent on the experience of 
the doctor, the facilities, and differences in man­
agement between countries or even hospitals. The 
differences that can be caused by this criterion 
make comparison between different series diffi­
cult. In our opinion, the recommendation of Knock- 
aert et al (23) and Durack and Street (8) to shorten 
this period to 3 days is not an improvement, for sev­
eral reasons. First, a better way to reduce bias is to 
change from a time-related criterion to a quality-re- 
lated criterion that requires a list of certain investi­
gations to be performed, as a minimum. We have 
used such a list (see Table 1). One could add direc­
tional investigations based on PDCs, performed 
within the first week of admission. Second, the ma­
jor reason to classify patients with FUO as such is 
to indicate that we deal with a difficult or poten­
tially difficult problem. In that context, maintaining 
the criterion of 1 week of clinical analysis seems 
appropriate to us, but perhaps in this regard a dif­
ference in admission policy between the Nether­
lands and the United States plays a role. Third, it is 
our experience that 3 days is often too short to ex­
clude diseases that are easy to diagnose, because 
the results of cultures and serology often take more 
than 2-3 days.
Even if the criteria are adapted, comparing series 
of patients with FUO remains troublesome. Geo­
graphic factors (18, 32, 35), age distribution of the 
study population (11), referral pattern, hospital set­
ting (16,20), and time and duration of study (changes 
in disease pattern and diagnostic management) influ­
ence the distribution of diagnostic categories. Selec­
tion bias increases when patients with FUO 
presenting at the outpatient department are in­
cluded; prospective case finding is much harder to re­
alize, and standardized diagnostic protocols are 
more difficult to implement. It would, however, be in­
structive to study this group of patients with a stan­
dardized protocol.
The median duration of hospitalization and of di­
agnostic phase was 27 days and 33 days, respec­
tively. These figures are in accordance with figures 
presented by Knockaert et al (25 and 19 days, re­
spectively) (23) and by our retrospective study (a 
median of 23 days of hospitalization) (5). In most 
other major series no such data are presented. In a
review of patients with FUO in community hospi­
tals, Kazanjian (20) found that it took a median of 19 
days to establish a diagnosis after a median dura­
tion of hospitalization of 11 days. It is possible that 
the difference between these data indicates a dif­
ference between the degree of difficulty of the pa­
tient groups.
The chance of reaching a diagnosis in patients with 
recurrent fever and fever lasting longer than 6 
months is relatively low. This was also found by 
Knockaert et al (22).
Different nomenclature for the group of patients 
without infections or neoplasms has been used in se­
ries on FUO. Terms used include “rheumatic 
diseases,” “multisystem diseases” (23), “dyscol- 
lagenosis” (4, 35), “collagen diseases” (12, 15,18, 30), 
“collagen vascular diseases” (1, 2, 13, 19, 20, 25), 
“connective tissue diseases” (16, 32, 34), and “inflam­
matory disorders” (8). Most series of FUO distin­
guish a category of diseases labeled as “collagen 
disorders,” which includes vasculitis and autoim­
mune diseases. Since collagen is involved in only a 
few of these disorders, and an autoimmune nature is 
often difficult to prove, we would break a lance for 
using the term “noninfectious inflammatory dis­
eases” (NIID) in the future. This categoiy could also 
include granulomatous disorders, like inflammatory 
bowel disease and sarcoidosis, usually fisted under 
miscellaneous disorders. A subdivision as presented 
in Tables 2 and 3 still allows for comparison with 
older series. NIID accompanied by fever are often 
classified as FUO. In these diseases, fever may pre­
cede more typical manifestations or serologic evi­
dence by months. Moreover, many of these diseases 
can only be diagnosed after prolonged observation 
and by exclusion.
Summary
Internal medicine wards in all 8 university hospi­
tals in the Netherlands participated in this prospec­
tive study of fever of unknown origin (FUO) from 
January 1992 until January 1994 in order to update 
information on the spectrum of diseases causing
FUO.
We used fixed epidemiologic entry criteria to 
achieve completeness of enrollment and to avoid un­
intended selection bias. After entry, immunocompe­
tent patients were included using criteria for FUO 
according to Petersdorf and Beeson (30). A stan­
dardized diagnostic protocol was used, and poten­
tially diagnostic clues (PDCs) and their use in the 
diagnostic process were prospectively registered. 
Thus, the criteria of classic FUO have been adjusted 
to modem times: immunocompromised patients are 
excluded, and the time-criterion “1 week in hospital
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without a diagnosis” has been replaced by a quality- 
criterion stating that certain investigations must be 
performed as a minimum, and PDCs must be fol­
lowed adequately for at least 1 week, without a diag­
nosis being reached.
A total of 167 immunocompetent patients with 
FUO were thus retrieved, of whom 43 (25.7%) had in­
fections, 21 (12.6%) had neoplasms, and 40 (24.0%) 
had noninfectious inflammatory diseases. No diag­
nosis was made in 50 patients (29.9%), 37 of whom re­
covered spontaneously.
This study confirms the changing spectrum of 
diseases causing FUO. Indeed, as shown by another 
recent study, the group of patients with FUO in 
whom no diagnosis can be made is expanding, and 
mostly it concerns self-limiting or benign fevers. 
Others have suggested that this trend is not really 
occurring (29). We did not place patients with dis­
eases of unknown origin in the “nondiagnosis” 
group, and indeed made presumptive diagnoses 
when necessary. Nevertheless, this category of un­
diagnosed fevers is increasing. We believe that the 
higher percentage of undiagnosed cases can be at­
tributed to the greater use of advanced diagnostic 
techniques attendant on an increased number of 
self-limited illnesses in patients meeting criteria for 
FUO. Because of ongoing development in diagnos­
tic techniques and the prospective influence on the 
spectrum of diseases causing FUO, studies should 
be performed regularly to update information on 
this subject. Because the number of outpatient 
evaluations for FUO is expected to increase, pa­
tients seen on an outpatient basis should be in­
cluded in future studies. To avoid unwanted 
selection bias, fixed epidemiologic entry criteria 
should be used to ensure completeness of enroll­
ment. To shorten the period of collecting data, mul- 
ticentric studies can be done using standardized 
diagnostic protocols.
In patients with recurrent fever or fever lasting 
longer than 6 months, the chance of reaching a diag­
nosis is significantly lower, and especially in this 
group one should exercise the greatest caution to 
avoid abundant and extensive diagnostic proce­
dures.
The diagnostic process in patients with FUO re­
mains an intriguing problem in medicine. Recent mi­
crobiologic techniques may be useful as an approach 
to the relatively large proportion of patients in whom 
we now fail to make a diagnosis.
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